Short answer · Medically reviewed summary · Last updated: 2026-04-07
Ledderhose disease, also known as plantar fibromatosis, is classified under ICD-10 code M72.2 (plantar fascial fibromatosis) and was previously classified under ICD-9 code 728.71. These codes are essential for medical billing, insurance authorization, and tracking the clinical documentation of this fibroproliferative disorder. What is Ledderhose disease and how is it coded? Ledderhose disease is a benign, non-malignant condition characterized by the development of firm, slow-growing nodules within the plantar fascia of the foot.
Ledderhose disease, also known as plantar fibromatosis, is classified under ICD-10 code M72.2 (plantar fascial fibromatosis) and was previously classified under ICD-9 code 728.71. These codes are essential for medical billing, insurance authorization, and tracking the clinical documentation of this fibroproliferative disorder.
Ledderhose disease is a benign, non-malignant condition characterized by the development of firm, slow-growing nodules within the plantar fascia of the foot. When clinicians document this condition for medical records, they use the ICD-10 code M72.2 to specify plantar fascial fibromatosis. Historically, the ICD-9 code 728.71 was utilized for the same diagnosis. Having accurate coding for Ledderhose disease is vital for patients when coordinating care between podiatrists, orthopedic surgeons, and physical therapists, as it ensures that the specific nature of the connective tissue disorder is recognized by healthcare systems.
Ledderhose disease typically manifests as one or more palpable, painless or mildly tender nodules along the medial or central arch of the foot. Over time, these nodules may increase in size or number, potentially leading to discomfort during weight-bearing activities or difficulty wearing certain types of footwear. While Ledderhose disease is not life-threatening, it can significantly impact quality of life due to chronic foot pain. At DiseaseMaps.org, we have seen 95 members share their experiences with this condition, highlighting the importance of peer support in managing the daily challenges of living with plantar fibromatosis.
Diagnosis is primarily clinical, based on a physical examination of the foot to identify characteristic nodules. To confirm the diagnosis of Ledderhose disease and rule out other pathologies, physicians may utilize the following diagnostic tools:
The exact cause of Ledderhose disease remains incompletely understood, but it is considered a multifactorial condition. There is clear evidence of a genetic predisposition, as many individuals with the condition have a family history of fibroproliferative disorders. Research suggests that plantar fibromatosis may occur more frequently in individuals of Northern European descent. While it is not strictly inherited in a simple Mendelian pattern, the presence of specific genetic markers likely influences susceptibility to the development of these fibromas.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the guidance of your physician with any questions regarding a medical condition.